Skip to content

Darunavir/ritonavir superior virologically and immunologically to comparator drugs over one year

Two-class ART just as good as three-class in the long-term, and has fewer side-effects

Botswanan isoniazid preventative therapy trial screens out large numbers of people who are already ill

Brain problems and peripheral neuropathy under-diagnosed in Asia and the Pacific

Randomised trial of food supplementation in food insecure patients ART inconclusive

Very low CD4, rural care, linked to higher risk of death on ARVs in African studies

Selenium improves ART response in Nigerian randomised study

`Put power to prevent HIV in the hands of women`, Bill and Melinda Gates tell AIDS Conference opening

Sexual risk-taking may be associated with MRSA in HIV-positive individuals